Evidence map›Paper›PMID 42974480›Full record

ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2026

Management of Obesity in Special Populations and Limited-Resource Settings: An Egyptian Medical Position Statement.

Mona A Hegazy, Amr Mattar, Maissa Mohamed Shawky, Dina Soliman, Maha Mowafy, Yasmine Mohamed NourEldin, Ahmed Madbouli Noweir, Mohamed Kamal Aboulghate, Mostafa Elshazli, May AbdelMoneim Hassaballa and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Mona A HegazyHepatology and Gastroenterology Division, Faculty of Medicine, Cairo University, Cairo, Egypt.ORCID 0009-0009-2030-0856
Amr MattarDepartment of Anaesthesia & SICU and Pain Management Kasr Alainy School of Medicine, Cairo University Cairo Egypt.
Maissa Mohamed ShawkySchool of Medicine, Cairo University, Cairo, Egypt.
Dina SolimanDepartment of Anesthesiology, SICU and Pain, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt.
Maha MowafyFamily Medicine Department Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt.
Yasmine Mohamed NourEldinClinical Nutrition Department Shifa Hospitals Group Cairo Egypt.
Ahmed Madbouli NoweirPublic Health and Nutrition High Institute of Public Health, Alexandria, Egypt.
Mohamed Kamal AboulghateDepartment of Anesthesiology Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt.
Mostafa ElshazliDepartment of General Surgery Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt.
May AbdelMoneim HassaballaDepartment of Internal Medicine & Nephrology Cairo University, Cairo, Egypt.
Shereen AbdelghaffarDepartment of Pediatric Diabetes and Endocrinology Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt.ORCID 0000-0002-2876-4809
Heba Morad BahgatDepartment of Internal Medicine, Diabetes and Endocrinology Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt.
Noha SabryDepartment of Psychiatry Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt.
Hesham Salah Eldin TahaDepartment of Cardiology Faculty of Medicine, Cairo University, Cairo, Egypt.ORCID 0000-0002-6558-8170
Inass ShaltoutDepartment of Internal Medicine and Diabetes Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt.
Mona YousryInternal Medicine, Diabetes Mellitus, and Endocrinology Division Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Obesity/adiposity-based chronic disease is a chronic progressive relapsing disease linked to several comorbidities, with rising prevalence in Egypt. Limited local guidelines and healthcare challenges necessitate evidence-based, culturally adapted strategies. Methods: The Egyptian Medical Association for the Study of Obesity convened a clinical multidisciplinary panel to develop consensus recommendations. Evidence was synthesized from literature, prioritizing resource-limited settings and special situations. Result: Assessment: Move beyond Body Mass Index to include waist circumference, waist/height ratio, body composition, and screening for obesity-related complications and diseases. Lifestyle Interventions: a-Nutrition: Mediterranean/dietary approach to stop hypertension diets, slow eating, and supervised fasting (eg Ramadan and Christian). b-Activity: Culturally tailored approaches (eg prayer-time movement and Arabic apps). c-Behavior: Cognitive-behavioral therapy and family-inclusive support. Pharmacotherapy: Use of approved agents (orlistat, naltrexone/bupropion, liraglutide, semaglutide, and tirzepatide) according to obesity-related complications and diseases and age group. Avoid GLP-1, GLP-1/GIP analogues in patients with medullary thyroid cancer, and all agents during pregnancy. Bariatric Surgery: Indicated for body mass index ≥40 kg/m Conclusion: These recommendations provide a pragmatic framework for obesity/adiposity-based chronic disease management in Egypt, emphasizing affordable, patient-centered care, and clinical multidisciplinary collaboration and policy support.

Indexed as

EgyptEMASOguidelineslimited resourcesobesity

Identifiers

PMID42974480
PMCPMC13726600

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.